Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)

Christian Kurzeder, Isabel Bover, Frederik Marḿe, Joern Rau, Patricia Pautier, Nicoletta Colombo, Domenica Lorusso, Petronella Ottevanger, Maria Bjurberg, Christian Marth, Pilar Barretina-Ginesta, Ignace Vergote, Anne Floquet, Josep M Del Campo, Sven Mahner, Lydie Bastíere-Truchot, Nicolas Martin, Mikkel Z. Oestergaard, Astrid Kiermaier, Carmen Schade-BrittingerSandra Polleis, Andreas Du Bois, Antonio Gonzalez-Martin

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)'. Together they form a unique fingerprint.

Medicine & Life Sciences